The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Atrium Innovations Announces the Renewal of its Normal Course Issuer Bid

Wednesday, November 07, 2012

Atrium Innovations Announces the Renewal of its Normal Course Issuer Bid16:15 EST Wednesday, November 07, 2012 QUEBEC CITY, Nov. 7, 2012 /PRNewswire/ - Atrium Innovations Inc. (TSX: ATB) announced today that it has filed with the Toronto Stock Exchange ("TSX"), and the TSX has accepted, a Notice of Intention to make a Normal Course Issuer Bid. Under its normal course issuer bid, Atrium intends to purchase up to 2,143,619 of its common shares, representing 10% of its public float as of October 31, 2012, comprised of 21,436,194 common shares. The average daily trading volume for the 6-month period preceding October 31, 2012 represents 20,969 common shares.  In accordance with the TSX requirements, a maximum daily purchase of the greater of 25% of this average or 1,000 shares may be made, which represents a total of 5,242 common shares. Purchases will be made on the open market by Atrium through the facilities of the TSX.  The purchases may commence on November 15, 2012 and will terminate on November 14, 2013, or on such earlier date as Atrium will have completed its purchases pursuant to the Notice of Intention to make a Normal Course Issuer Bid filed with the TSX.  Atrium will cancel any common shares purchased pursuant to the normal course issuer bid. Atrium will pay the market price of common shares on the TSX at the time of purchase and no purchases of common shares will be made other than open-market purchases. Under its previous normal course issuer bid which was announced on November 9, 2011 and revised on March 20, 2012, Atrium repurchased a total of 1,175,008 common shares as at October 31, 2012 at the weighted average price per share of $10.8818. Atrium considers that repurchasing its common shares is a sound business and financial decision as shares in circulation will be reduced and the proportionate interest of all remaining shareholders in the share capital of Atrium will be increased on a pro rata basis. No appraisal or valuation regarding Atrium, its material assets or securities was prepared within the two years preceding the date of the Notice of Intention to make a Normal Course Issuer Bid. About Atrium Innovations Atrium Innovations Inc. is a globally-recognized leader in the development, manufacturing, and commercialization of innovative, science-based dietary supplements endorsed by health professionals. The Company distributes its extensive portfolio of products mainly in the healthcare practitioner and health food and specialized store channels, with a primary focus in North America and Europe. Atrium is at the forefront of science, innovation and education in the dietary supplement industry.  The Company has over 1,100 employees and operates seven manufacturing facilities. Additional information is available at www.atrium-innovations.com. Cautionary Note and Forward-Looking Statements This press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. These forward-looking statements, including financial outlooks, may involve, but are not limited to, comments with respect to the Company's business or financial objectives, its strategies or future actions, its targets, expectations for financial condition or outlook for operations and future contingent payments. Words such as "may", "will", "would", "could", "expect", "believe", "plan", "anticipate", "intend", "estimate", "continue", or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances.  The Company considers these assumptions to be reasonable based on information currently available to it, but cautions the reader that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its business. For additional information with respect to these and other factors and assumptions underlying the forward-looking statements made in this press release, see the Company's quarterly and annual Management Discussion and Analysis for the fiscal year ended December 31, 2010 filed with the Canadian securities commissions. The forward-looking information set forth herein reflects the Company's expectations as at the date of this press release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law. SOURCE ATRIUM INNOVATIONS INC.For further information: <p> </p> <p> <b>Investor Relations</b>: <br/> Mario Paradis<br/> Vice President and Chief Financial Officer<br/> Tel.: 418 652-1116<b> </b><br/> <a cr="true" href="mailto:mp@atrium-innovations.com">mp@atrium-innovations.com</a>  </p> <p> Pierre Boucher<br/> MaisonBrison Communications<br/> Tel.: 514 731-0000, ext. 237<br/> <a cr="true" href="mailto:pierre@maisonbrison.com">pierre@maisonbrison.com</a> </p> <p> <b>Media Relations:</b><br/> Amélie Germain<br/> Director of Communications<br/> Tel.: 418 652-1116<b> </b><br/> <a cr="true" href="mailto:ag@atrium-innovations.com">ag@atrium-innovations.com</a><br/> <br/> </p>